Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

Long-term antiandrogen use may increase aggressive prostate cancer risk.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Dr. Connelly agrees that linear basal cell carcinomas might be more aggressive but highlights the study's lack of clear criteria to identify them.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Male pattern baldness may be linked to prostate cancer risk.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Complete surgical removal and regular check-ups are essential for treating a rare skin cancer, and hair transplant can help fix scars from cancer surgery.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

Finasteride reduces prostate cancer risk but may increase aggressive cancer risk slightly.

A rare skin cancer on a man's elbow was successfully treated with surgery, showing no recurrence after one year.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

A young woman with a rare skin cancer was diagnosed late because her symptoms were unusual for the disease.

Hair transplantation can improve scars after removing a rare skin cancer.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.